Cat.#: ACPP-1361
| Despition | PAX2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1162 | Recombinant Human GDNF Protein (Fc Tag) (AC1162) | 50 µg | inquiry |
| ACPP-1259 | Usherin Blocking Peptide (AC1259) | 250 µg | inquiry |
| ACPP-1684 | Human GNB3 Protein (AC1684) | 5 µg | inquiry |
| ACPP-1126 | Recombinant Human Peripherin Protein (AC1126) | 25 µl | inquiry |
| ACPP-1189 | PDE6C Blocking Peptide (AC1189) | 250 µg | inquiry |
| ACPP-1421 | Human il-6 Protein, HEK (AC1421) | 2 µg | inquiry |
| ACPP-1456 | Human HEXA Protein (AC1456) | 5 µg | inquiry |
| ACPP-1321 | NPY5R Blocking Peptide (AC1321) | 250 µg | inquiry |
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.